Journal article · 2025 · Open access
CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials
BMJ, 389, e081124 · Published 14 April 2025 · DOI 10.1136/bmj-2024-081124
In brief
“CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials” is a 2025 journal article by Sally Hopewell and 38 co-authors, published in BMJ. OpenAlex counts 307 citations as of 15 November 2026. It is open access under a CC BY licence: the full text is free to read at BMJ.
- Citations
- 307
- Most cited in
- 2026 (228)
- Field-weighted impact
- 63.15
- References
- 486
- Authors
- 39
Abstract
Critical appraisal of the quality of randomised trials is possible only if their design, conduct, analysis, and results are completely and accurately reported. Without transparent reporting of the methods and results, readers will not be able to fully evaluate the reliability and validity of trial findings. The CONSORT (Consolidated Standards of Reporting Trials) statement aims to improve the quality of reporting and provides a minimum set of items to be included in a report of a randomised trial. CONSORT was first published in 1996 and was updated in 2001 and 2010. CONSORT comprises a checklist of essential items that should be included in reports of randomised trials and a diagram for documenting the flow of participants through a trial. The CONSORT statement has been updated (CONSORT 2025) to reflect recent methodological advancements and feedback from end users, ensuring that it remains fit for purpose. Here, we present the updated CONSORT explanation and elaboration document, which has been extensively revised and describes the rationale and scientific background for each CONSORT 2025 checklist item and provides published examples of good reporting. The objective is to enhance the use, understanding, and dissemination of CONSORT 2025 and provide guidance to authors about how to improve the reporting of their trials and ensure trial reports are complete, and transparent.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Hopewell, S., Chan, A., Collins, P. G. S., Hróbjartsson, A., Moher, D., Schulz, K. F., Tunn, R., Aggarwal, R., Berkwits, M., Berlin, J. A., Bhandari, N., Butcher, N. J., Campbell, M., Chidebe, R. C., Elbourne, D. R., Farmer, A. A., Fergusson, D. A., Golub, R. M., Goodman, S. N., . . . Boutron, I. (2025). CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials. BMJ, 389, e081124. https://doi.org/10.1136/bmj-2024-081124
MLA 9
Hopewell, Sally, et al. “CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials.” BMJ, vol. 389, 2025, p. e081124. https://doi.org/10.1136/bmj-2024-081124.
Chicago
Hopewell, Sally, An‐Wen Chan, Professor Gary S. Collins, Asbjørn Hróbjartsson, David Moher, Kenneth F. Schulz, Ruth Tunn, et al. 2025. “CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials.” BMJ 389: e081124. https://doi.org/10.1136/bmj-2024-081124.
Harvard
Hopewell, S. et al. (2025) ‘CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials’, BMJ, 389, p. e081124. doi:10.1136/bmj-2024-081124.
IEEE
S. Hopewell et al., “CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials,” BMJ, vol. 389, p. e081124, 2025, doi: 10.1136/bmj-2024-081124.
BibTeX
@article{hopewell2025consort,
title = {{CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials}},
author = {Hopewell, Sally and Chan, An‐Wen and Collins, Professor Gary S. and Hróbjartsson, Asbjørn and Moher, David and Schulz, Kenneth F. and Tunn, Ruth and Aggarwal, Rakesh and Berkwits, Michael and Berlin, Jesse A. and Bhandari, Nita and Butcher, Nancy J. and Campbell, Marion and Chidebe, Runcie C.W. and Elbourne, Diana R. and Farmer, Andrew A. and Fergusson, Dean A. and Golub, Robert M. and Goodman, Steven N. and Hoffmann, Tammy and Ioannidis, John P. A. and Kahan, Brennan C and Knowles, Rachel Louise and Lamb, Sarah E and Lewis, Steff C. and Loder, Elizabeth and Offringa, Martin and Ravaud, Philippe and Richards, Dawn P. and Rockhold, Frank W. and others},
journal = {BMJ},
year = {2025},
volume = {389},
pages = {e081124},
doi = {10.1136/bmj-2024-081124},
url = {https://doi.org/10.1136/bmj-2024-081124}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2024 | 1 | |
| 2025 | 78 | |
| 2026 | 228 |
Its field-weighted citation impact is 63.15: it has been cited 63.15 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- reporting guidelines
- randomised trials
- trial reporting quality
- reporting checklist
- flowcharts
- critical appraisal
- research transparency
- trial design and conduct
Work with this paper
Most-cited papers in Decision Sciences
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviewsMatthew James Page, Joanne E. McKenzie, Patrick M. Bossuyt and 23 more · BMJ · 2021 · 144,919 citations
- Evaluating Structural Equation Models with Unobservable Variables and Measurement ErrorClaes Fornell, David F. Larcker · Journal of Marketing Research · 1981 · 118,336 citations
- Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternativesLi‐tze Hu, Peter M. Bentler · Structural Equation Modeling A Multidisciplinary Journal · 1999 · 117,461 citations
- Common method biases in behavioral research: A critical review of the literature and recommended remedies.Philip M. Podsakoff, SCOTT B. MACKENZIE, Jeong Yeon Lee and 1 more · Journal of Applied Psychology · 2003 · 89,248 citations
- Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statementDavid Moher, Alessandro Liberati, Jennifer Tetzlaff and 2 more · BMJ · 2009 · 85,524 citations
Questions about this paper
How do I cite this paper in APA style?
Hopewell, S., Chan, A., Collins, P. G. S., Hróbjartsson, A., Moher, D., Schulz, K. F., Tunn, R., Aggarwal, R., Berkwits, M., Berlin, J. A., Bhandari, N., Butcher, N. J., Campbell, M., Chidebe, R. C., Elbourne, D. R., Farmer, A. A., Fergusson, D. A., Golub, R. M., Goodman, S. N., . . . Boutron, I. (2025). CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials. BMJ, 389, e081124. https://doi.org/10.1136/bmj-2024-081124
How many times has this paper been cited?
307 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at BMJ.
Who wrote this paper?
Sally Hopewell, An‐Wen Chan, Professor Gary S. Collins, Asbjørn Hróbjartsson, David Moher, Kenneth F. Schulz, Ruth Tunn, Rakesh Aggarwal, Michael Berkwits, Jesse A. Berlin, Nita Bhandari, Nancy J. Butcher and 27 more.
What is the DOI of this paper?
10.1136/bmj-2024-081124. The permanent link is https://doi.org/10.1136/bmj-2024-081124.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.